BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11705869)

  • 21. [Modified CLIP score as a new prognostic index for patients with hepatocellular carcinoma].
    Han SH; Han SY; Go BS; Kim MJ; Lee JH; Koo YH; Ryu SH; Cho JH; Jang JS; Lee JH; Roh MH; Choi SR; Choi JC; Lee SW
    Korean J Hepatol; 2006 Jun; 12(2):209-20. PubMed ID: 16804346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.
    Ren Y; Poon RT; Tsui HT; Chen WH; Li Z; Lau C; Yu WC; Fan ST
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5996-6001. PubMed ID: 14676125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and prognostic factors in patients with hepatocellular carcinoma.
    Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
    Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.
    Kudo M; Chung H; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
    Hepatology; 2004 Dec; 40(6):1396-405. PubMed ID: 15565571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program.
    Ueno S; Tanabe G; Sako K; Hiwaki T; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    Hepatology; 2001 Sep; 34(3):529-34. PubMed ID: 11526539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of predictive value of Okuda, TNM, CLIP and JIS staging systems for hepatocellular carcinoma patients].
    Lee SW; Han SY; Kim KT; Baek YH; Koh IY; Kim BH; Park EH; Jang JS; Roh MH; Choi JC
    Korean J Hepatol; 2007 Jun; 13(2):196-207. PubMed ID: 17585193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
    Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of staging systems to predict survival in hepatocellular carcinoma.
    Pascual S; Zapater P; Such J; García-Herola A; Sempere L; Irurzun J; Palazón JM; Carnicer F; Pérez-Mateo M
    Liver Int; 2006 Aug; 26(6):673-9. PubMed ID: 16842323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.
    Hsu CY; Huang YH; Hsia CY; Su CW; Lin HC; Loong CC; Chiou YY; Chiang JH; Lee PC; Huo TI; Lee SD
    J Hepatol; 2010 Jul; 53(1):108-17. PubMed ID: 20451283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.
    Yau T; Yao TJ; Chan P; Ng K; Fan ST; Poon RT
    Cancer; 2008 Nov; 113(10):2742-51. PubMed ID: 18853421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.
    Saffroy R; Lelong JC; Azoulay D; Salvucci M; Reynes M; Bismuth H; Debuire B; Lemoine A
    Br J Cancer; 1999 Feb; 79(3-4):604-10. PubMed ID: 10027337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
    Lin CY; Kuo CS; Lu CL; Wu MY; Huang RF
    Nutr Cancer; 2010; 62(2):190-7. PubMed ID: 20099193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
    Toyoda H; Kumada T; Osaki Y; Oka H; Urano F; Kudo M; Matsunaga T
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1528-36. PubMed ID: 17162244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
    Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG
    Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of serum levels of cytokines and intercellular adhesion molecule-1 (ICAM-1) in astrocytic tumours.
    Nano R; Capelli E; Argentina F; Facoetti A; Gerzeli G
    Cell Mol Biol (Noisy-le-grand); 2003 Jun; 49(4):525-8. PubMed ID: 12899444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.